Identification of International Classification of Functioning, Disability and Health (ICF) codes most frequently used to describe functioning in children: a systematic review - Top-Institutions - MDSpire

Identification of International Classification of Functioning, Disability and Health (ICF) codes most frequently used to describe functioning in children: a systematic review

  • By

  • Idalina Maria Santos Vieira Lisboa Bordalo

  • Carla Martins Pereira

  • César Fonseca

  • Isabel Bico

  • June 19, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    CanChild Centre for Childhood Disability Research, McMaster University
    CanChild Centre for Childhood Disability Research, McMaster University

    Hamilton, Ontario

    Key Differentiators

    • Childhood Disability Research
    • Pediatrics

  • #2

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatrics
    • Pediatric Research

  • #3

    Leiden University Medical Center
    Leiden University Medical Center

    Leiden, Netherlands

    Key Differentiators

    • Pediatrics
    • Rheumatology

  • #4

    University Medical Center Groningen
    University Medical Center Groningen

    Groningen, Netherlands

    Key Differentiators

    • Pediatrics

  • #5

    UCSF Benioff Children’s Hospital
    UCSF Benioff Children’s Hospital

    San Francisco, California

    Key Differentiators

    • Pediatrics
    • Cardiology

Original Source(s)

Identification of International Classification of Functioning, Disability and Health (ICF) codes most frequently used to describe functioning in children: a systematic review

  • by Idalina Maria Santos Vieira Lisboa Bordalo, Carla Martins Pereira, César Fonseca, Isabel Bico

  • June 19, 2026

Related Content

Correction: Adenosine Dose and Cardioversion in Pediatric Supraventricular Tachycardia: A Systematic Review and Meta-Analysis

Season-matched comparison of pediatric respiratory pathogen detection patterns before and after the lifting of COVID-19 restrictions in Guangzhou

FDA Expands Gene Therapy for Younger Patients

Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.